Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
Should You Buy Newmont Corporation (NEM) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
NEMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Add The Cooper Companies (COO) to Your Portfolio
by Zacks Equity Research
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
DVANegative Net Change ALGNPositive Net Change COONegative Net Change MEDPNegative Net Change
medical medical-devices
QIAGEN (QGEN) to Enhance Forensics With New Partnership
by Zacks Equity Research
QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.
RMDPositive Net Change QGENPositive Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
BSXNegative Net Change ECLNegative Net Change ISRGNegative Net Change ALGNPositive Net Change
medical medical-devices
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
ECLNegative Net Change DVANegative Net Change VEEVPositive Net Change ITGRNegative Net Change
medical medical-devices
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ECLNegative Net Change DVANegative Net Change VEEVPositive Net Change CTLTNegative Net Change
medical medical-devices
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
BSXNegative Net Change ECLNegative Net Change OFIXPositive Net Change ALGNPositive Net Change
medical medical-devices
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
by Zacks Equity Research
Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
RMDPositive Net Change TFXPositive Net Change HIMSPositive Net Change HITINegative Net Change
medical medical-devices
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
BSXNegative Net Change ALGNPositive Net Change RMDPositive Net Change AMNPositive Net Change
earnings medical medical-devices
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
by Zacks Equity Research
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
BSXNegative Net Change ECLNegative Net Change ALGNPositive Net Change PACBPositive Net Change
earnings medical medical-devices
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
RMDPositive Net Change HAEPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CMMBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Snap (SNAP) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SNAPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Byline Bancorp (BY) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
First Community Bancshares (FCBC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FCBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings
by Moumi Mondal
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
MDTPositive Net Change VCYTPositive Net Change BRBRNegative Net Change HIMSPositive Net Change
medical medical-devices
Why Alcon (ALC) Might Surprise This Earnings Season
by Zacks Equity Research
Alcon (ALC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ALCNegative Net Change
medical medical-devices
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
by Zacks Equity Research
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
BSXNegative Net Change ALGNPositive Net Change RMDPositive Net Change CTLTNegative Net Change
earnings medical medical-devices
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
BSXNegative Net Change ALGNPositive Net Change RMDPositive Net Change INGNPositive Net Change
earnings medical medical-devices
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
BSXNegative Net Change ECLNegative Net Change ALGNPositive Net Change QDELNegative Net Change
earnings medical medical-devices
Top Research Reports for Procter & Gamble, Verizon & Intuitive Surgical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Verizon Communications Inc. (VZ) and Intuitive Surgical, Inc. (ISRG).
VZPositive Net Change PGNegative Net Change NSCPositive Net Change HESNegative Net Change ISRGNegative Net Change ALLNegative Net Change
communications consumer-staples medical-devices
Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down
by Zacks Equity Research
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences' (EXAS) first-quarter top line.
RMDPositive Net Change EXASPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
by Zacks Equity Research
Investors are optimistic about Labcorp (LH), led by strategic acquisitions and strong expansion in the Biopharma Laboratory.
LHPositive Net Change RMDPositive Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
Phibro (PAHC) Q3 Earnings and Revenues Beat, Gross Margin Down
by Zacks Equity Research
Phibro's (PAHC) impressive fiscal 2024 third-quarter performance continues to be driven by the Animal Health segment.
PAHCPositive Net Change EHCNegative Net Change INSPNegative Net Change HIMSPositive Net Change
earnings medical medical-devices
National Vision (EYE) Q1 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
National Vision (EYE) delivers improved revenues in the first quarter of 2024 in a challenging macro environment.
EHCNegative Net Change EYEPositive Net Change INSPNegative Net Change HIMSPositive Net Change
earnings medical medical-devices